- Case report
- Open Access
- Open Peer Review
Paraneoplastic cerebellar degeneration associated with lymphoepithelial carcinoma of the tonsil
© Henke et al.; licensee BioMed Central Ltd. 2013
- Received: 23 May 2013
- Accepted: 9 October 2013
- Published: 17 October 2013
Paraneoplastic cerebellar degeneration (PCD) is a classical tumor-associated, immune-mediated disease typically associated with gynecological malignancies, small-cell lung-cancer or lymphoma.
Here we present the case of a 38-year old male with an over 12 months rapidly progressive cerebellar syndrome. Extensive diagnostic workup revealed selective hypermetabolism of the right tonsil in whole-body PET. Histological examination after tonsillectomy demonstrated a lymphoepithelial carcinoma of the tonsil and the tongue base strongly suggesting a paraneoplastic cause of the cerebellar syndrome. To the best of our knowledge this is the first case of an association of a lymphoepithelial carcinoma, a rare pharyngeal tumor, with PCD.
In cases of classical paraneoplastic syndromes an extensive search for neoplasms should be performed including whole-body PET to detect tumors early in the course of the disease.
- Paraneoplastic syndrome
- Subacute cerebellar degeneration
Paraneoplastic cerebellar degeneration (PCD) is a classical paraneoplastic syndrome (PNS) of the CNS  often associated with onconeural antibodies leading to a T-cell mediated destruction of Purkinje cells in the cerebellum . Typically, PCD occurs in patients with ovarian cancer, breast-cancer, small-cell lung-cancer (SCLC) or Hodgkin’s lymphoma . Nonetheless, PCD can be associated with other malignancies and can occur up to 5 years before detection of the primary tumor. Here, we describe a patient who developed subacute cerebellar degeneration which was classified as a paraneoplastic syndrome upon histological diagnosis of a lymphoepithelial carcinoma of the tonsil and tongue base. To the best of our knowledge, this is the first published case of PCD associated with a lymphoepithelial carcinoma.
A 38-year old, previously healthy man presented on his first admission with a 5-day history of dizziness, slurring of speech and disturbance of gait and balance. There was a family history of multiple sclerosis (paternal grandfather and a paternal cousin) but not of any other cerebellar disease. The patient smoked 30 cigarettes per day for the last 25 years. Neurological examination revealed dysarthria, trunk and gait ataxia and exaggerated tendon reflexes of the upper and lower limbs. Spontaneous nystagmus was absent and pursuit eye movements were smooth. Routine hematology was normal but the cerebrospinal fluid (CSF) showed elevated cell count (407 lymphocytes/μl) and protein (1 g/l) while glucose and lactate were normal. CSF cytology provided no evidence of malignant cells but oligoclonal IgG bands were detected in the CSF. HSV- and VZV-PCRs were negative. Cerebellitis caused by an unknown infectious agent was suspected and a polyvalent intravenous therapy with aciclovir, ceftriaxone and ampicilline was initiated which halted disease progression. Cerebral MRI was unremarkable. During the next months he underwent two neurorehabilitation treatments without relevant efficacy on the residual symptoms, but 10 months after disease onset he rapidly deteriorated.
On admission this time he reported severe gait and trunk unsteadiness, difficulties in writing, massive slurring of speech and problems of swallowing. On physical examination he showed a substantial weight loss of 15 kg over the last 12 months but no enlargement of lymph nodes. Neurological examination revealed a cerebellar syndrome with an exaggerated horizontal nystagmus during lateral gaze and a scanning dysarthria. Fixation suppression of the vestibulo-ocular reflex was abolished. There was no muscle weakness or sensory loss and his limb reflexes were normal but plantar responses were bilaterally extensor. He showed severe dysmetria of all four limbs and trunk and gait ataxia. Walking without aid was impossible.
This is the first published case of a lymphoepithelial carcinoma associated with PCD. Classification as a classical paraneoplastic syndrome and detection of a malignant tumor within twelve months after the onset of cerebellar symptoms establishes the diagnosis of a definite PNS . Despite missing onconeural antibodies, the substantially slowed disease progression after tumor resection and the initial responsiveness to steroids largely exclude other differential diagnoses. The pathogenesis in our case as in most other PCD cases  is most likely a T-cell mediated cytotoxic autoimmune response against Purkinje cells .
List of PCD cases in PubMed not associated with gynecological, breast, or lung cancer, or lymphoma (state: December 2012; search key words: “paraneoplastic cerebellar degeneration”), f: female; m: male)
Akpinar et al.
Bataller et al.
Sola-Valls et al.
Langerhans cell histiocytosis
Goldberg-Stern et al.
Tsukamoto et al.
Meglic et al.
Balducci et al.
Debes et al.
Xia et al.
Sutton et al.
Salmerón-Ato et al.
renal cell carcinoma
Hens et al.
Ammar et al.
transitional cell carcinoma
Greenlee et al.
Kaluza et al.
testicular germ cell tumor
van Warrenburg et al.
Greenlee et al.
Matschke J et al.
Hauspy et al.
Maeda et al.
The data in Table 1 reveal atypically localized malignancies in many different body regions belonging mostly to either the hematological/immunological system (lymphomas, Langerhans’ cell histiocytosis, thymus carcinoma), the gastro-intestinal system (esophagus, gastric, colon or pancreas carcinoma) or the urogenital system (kidney, bladder, testis or prostate cancer).
In our case histological examination demonstrated a lymphoepithelial carcinoma, which is a rare tumor entity, typically localized in the nasopharynx region. Due to the histological association with lymphoid tissue, tumor tissue can arise from all pharyngeal regions where lymphatic tissue is regularly located i.e. the tonsil, the hypopharynx, the tongue base and the paranasal sinuses [3–5]. Cases of lymphoepithelioma-like carcinomas of the salivary glands are also reported . Lymphoepitheliomas are poorly differentiated tumors which contain tumor cells of epithelial origin in association with a diffuse infiltration of lymphocytes, plasma cells or eosinophils, which has led to coining to the term “lympho-epithelioma”. In some cases, also squamous cell carcinoma cells can be detected. The elevated tumor marker SCC in our case raises the possibility of a potential squamous cell-portion. No antibodies associated with lymphoma (anti-Tr) or SCLC (anti-Hu, -CV2, -Ri, -Ma2, -amphiphysin) were detected so that the origin of the antigenic structure that resulted in PCD remains unclear. We have not performed immunohistochemistry on rodent brain tissue sections with the patient’s CSF to search for new reactivities, which can be considered a limitation of this report.
There are only very few reports about paraneoplastic syndromes in association with lymphoepithelioma-like carcinomas of various other organs (polymyositis, nephrotic syndrome, erythema elevatum diutinum) [7–9] but onconeural antibodies have not been described in these cases. Classical neurological PNS have not yet been reported in association with this tumor entity so that this is the first case report of PCD associated with a lymphoepithelial carcinoma.
Due to the localized state of the tumor in our patient complete surgical removal of the carcinoma was feasible without additional radio- or chemotherapy. Regarding the pathophysiological concept of PNS the tumor resection is the most important part of the therapy to reduce the amount of antigenic tumor cells. In addition, immunomodulatory treatment with intravenous immunoglobulins occasionally shows efficacy in early stages of the disease .
Our case report highlights the usefulness of an extended tumor search - including a whole-body PET/CT scan - when a paraneoplastic syndrome is suspected . A whole-body PET/CT scan provides superior sensitivity to detect small or atypically localized neoplasms, a precondition to initiate causal therapy by surgical removal.
The patient gave his written and informed consent for this case report to be published.
- Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler C, Verschuren JJ, Vincent A, Voltz R: Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004, 75 (8): 1135-1140. 10.1136/jnnp.2003.034447.View ArticlePubMedPubMed CentralGoogle Scholar
- Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008, 7 (4): 327-340. 10.1016/S1474-4422(08)70060-7.View ArticlePubMedPubMed CentralGoogle Scholar
- Ferlito A: Primary lymphoepithelial carcinoma of the hypopharynx. J Laryngol Otol. 1977, 91 (4): 361-367. 10.1017/S0022215100083791.View ArticlePubMedGoogle Scholar
- Brennan B: Nasopharyngeal carcinoma. Orphanet J Rare Dis. 2006, 1: 23-10.1186/1750-1172-1-23.View ArticlePubMedPubMed CentralGoogle Scholar
- von Zalka E: Ueber lymphoepitheliom und reticulumsarkom. J Cancer Res Clin Oncol. 1935, 41 (1): 9-Google Scholar
- Hsiung CY, Huang CC, Wang CJ, Huang EY, Huang HY: Lymphoepithelioma-like carcinoma of salivary glands: treatment results and failure patterns. Br J Radiol. 2006, 79 (937): 52-55. 10.1259/bjr/17905092.View ArticlePubMedGoogle Scholar
- Koppula BR, Pipavath S, Lewis DH: Epstein-Barr virus (EBV) associated lymphoepithelioma-like thymic carcinoma associated with paraneoplastic syndrome of polymyositis: a rare tumor with rare association. Clin Nucl Med. 2009, 34 (10): 686-688. 10.1097/RLU.0b013e3181b53f5a.View ArticlePubMedGoogle Scholar
- Arenas MD, Gil MT, Malek T, Farre J, Fernandez Morejon FJ, Arriero JM, Aranda I, Moledous A, Alvarez-Ude F: Nephrotic syndrome as paraneoplastic manifestation of a primary pulmonary lymphoepithelioma-like carcinoma. Clin Nephrol. 2009, 72 (3): 206-210.View ArticlePubMedGoogle Scholar
- Liu TC, Chen IS, Lin TK, Lee JY, Kirn D, Tsao CJ: Erythema elevatum diutinum as a paraneoplastic syndrome in a patient with pulmonary lymphoepithelioma-like carcinoma. Lung Cancer. 2009, 63 (1): 151-153. 10.1016/j.lungcan.2008.05.006.View ArticlePubMedGoogle Scholar
- Rees JH: Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage. J Neurol Neurosurg Psychiatry. 2004, 75 (Suppl 2): ii43-ii50.PubMedPubMed CentralGoogle Scholar
- Titulaer MJ, Soffietti R, Dalmau J, Gilhus NE, Giometto B, Graus F: Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011, 18 (1): e3-e19. 10.1111/j.1468-1331.2010.03137.x.View ArticleGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://0-www.biomedcentral.com.brum.beds.ac.uk/1471-2377/13/147/prepub
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.